Bevacizumab, irinotecan, and temozolomide with re-irradiation in adult recurrent medulloblastoma: A first case report

被引：1
|
作者：
Yamauchi, Takahiro [1 ,4 ]
Kitai, Ryuhei [1 ,2 ]
Arai, Hiroshi [3 ]
Kidoguchi, Masamune [3 ]
Isozaki, Makoto [1 ]
Kodera, Toshiaki [1 ]
Kikuta, Ken-ichiro [1 ]
机构：
[1] Univ Fukui, Div Med, Dept Neurosurg, Fac Med Sci, 23-3 Matsuokashimoaizuki,Eiheiji Cho, Fukui 9101193, Japan
[2] Kaga Med Ctr, Dept Neurosurg, Kaga, Ishikawa, Japan
[3] Municipal Tsuruga Hosp, Dept Neurosurg, Tsuruga, Fukui, Japan
[4] Univ Fukui, Dept Hematol & Oncol, Fac Med Sci, Fukui, Japan
来源：
INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT | 2021年 / 25卷
关键词：
Adult recurrent medulloblastoma; Bevacizumab; Irinotecan; Temozolomide; PROGNOSTIC-FACTORS; PHASE-II; CHILDREN; CHEMOTHERAPY; SURVIVAL; THERAPY; TUMOR;
D O I：
10.1016/j.inat.2021.101249
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Medulloblastoma in adults is very rare, and there is no effective therapy for its initial appearance or recurrence. We present a case of a 40-year-old male with recurrent medulloblastoma despite initial radiochemotherapy. He received re-irradiation and 6 courses of bevacizumab, irinotecan, and temozolomide after which he remained stable for 6 months. This regimen may be promising for recurrent medulloblastoma in adults.
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Efficacy of temozolomide and bevacizumab for the treatment of leptomeningeal dissemination of recurrent glioblastoma: A case report
    Okita, Yoshiko
    Nonaka, Masahiro
    Umehara, Toru
    Kanemura, Yonehiro
    Kodama, Yoshinori
    Mano, Masayuki
    Nakajima, Shin
    ONCOLOGY LETTERS, 2015, 9 (04) : 1885 - 1888
  • [42] Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients
    Maximilian Niyazi
    Nathalie Lisa Jansen
    Maya Rottler
    Ute Ganswindt
    Claus Belka
    Radiation Oncology, 9
  • [43] Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report
    Torcuator, Roy
    Zuniga, Richard
    Loutfi, Randa
    Mikkelsen, Tom
    JOURNAL OF NEURO-ONCOLOGY, 2009, 93 (03) : 409 - 412
  • [44] Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients
    Niyazi, Maximilian
    Jansen, Nathalie Lisa
    Rottler, Maya
    Ganswindt, Ute
    Belka, Claus
    RADIATION ONCOLOGY, 2014, 9
  • [45] Stereotactic Radiosurgery Re-Irradiation for Recurrent Glioblastoma: A Single Institution Experience
    Duriseti, Sai
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (05): : E8 - E9
  • [46] Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option
    Maya Flieger
    Ute Ganswindt
    Silke Birgit Schwarz
    Friedrich-Wilhelm Kreth
    Jörg-Christian Tonn
    Christian la Fougère
    Lorenz Ertl
    Jennifer Linn
    Ulrich Herrlinger
    Claus Belka
    Maximilian Niyazi
    Journal of Neuro-Oncology, 2014, 117 : 337 - 345
  • [47] Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better
    Palmer, Joshua D.
    Siglin, Joshua
    Yamoah, Kosj
    Dan, Tu
    Champ, Colin E.
    Bar-Ad, Voichita
    Werner-Wasik, Maria
    Evans, James J.
    Kim, Lyndon
    Glass, Jon
    Farrell, Christopher
    Andrews, David W.
    Shi, Wenyin
    JOURNAL OF NEURO-ONCOLOGY, 2015, 124 (02) : 215 - 221
  • [48] Re-irradiation for locally recurrent refractory breast cancer
    Merino, Tomas
    Tran, William T.
    Czarnota, Gregory J.
    ONCOTARGET, 2015, 6 (33) : 35051 - 35062
  • [49] A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors
    Jonathan Metts
    Brittany Harrington
    Emad Salman
    Scott M. Bradfield
    Jennifer Flanary
    Maua Mosha
    Ernest Amankwah
    Stacie Stapleton
    Child's Nervous System, 2022, 38 : 919 - 928
  • [50] Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study
    Sahebjam, Solmaz
    Forsyth, Peter A.
    Tran, Nam D.
    Arrington, John A.
    Macaulay, Robert
    Etame, Arnold B.
    Walko, Christine M.
    Boyle, Theresa
    Peguero, Edwin N.
    Jaglal, Michael
    Mokhtari, Sepideh
    Enderling, Heiko
    Raghunand, Natarajan
    Gatewood, Tyra
    Long, Wendy
    Dzierzeski, Jennifer L.
    Evernden, Brittany
    Robinson, Timothy
    Wicklund, Melissa C.
    Kim, Sungjune
    Thompson, Zachary J.
    Chen, Dung-Tsa
    Chinnaiyan, Prakash
    Yu, Hsiang-Hsuan Michael
    NEURO-ONCOLOGY, 2021, 23 (04) : 677 - 686
12345